Details of the Drug | DrugMAP

General Information of Drug (ID: DMY78E0)

Drug Name

ADCT-301

Synonyms

camidanlumab tesirine

Indication

Disease Entry	ICD 11	Status	REF
Hodgkin lymphoma	2B30	Phase 2	[1]
Acute lymphoblastic leukaemia	2A85	Phase 1	[2]
Acute myeloid leukaemia	2A60	Phase 1	[2]
Lymphoma	2A80-2A86	Phase 1	[3]
------------------------------------------------------------------------------------

Cross-matching ID

TTD ID: D0LL1N

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

References

1	ClinicalTrials.gov (NCT04052997) Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)